Official VapoCept® Distribution & Reference Desk Cycle 2026 US Climate Inventory Active · Direct Warehouse Allocation
Ingredients & Lab Assay Biological Mechanisms Supplement Facts & Label Direct Manufacturer Pricing Verified Buyer Reviews Frequently Asked Questions Usage Protocol & Dosage 60-Day Results Timeline Safety & Interactions Guide 60-Day Guarantee Decoded Batch & Lot Authenticity Portal Clinical Education Blog Claim Factory Stock · From $49
← Back to Clinical Blog
Medical Monograph

L-Citrulline vs. L-Arginine: Maximizing Cerebral Microvascular Flow

Medically Reviewed by Dr. Marcus Vance, PharmD · Published: October 14, 2026

While L-arginine directly donates nitrogen atoms to endothelial nitric oxide synthase (eNOS), oral arginine is heavily metabolized in the gut and liver. L-citrulline bypasses first-pass hepatic metabolism completely, converting systemically in vascular endothelial tissue into sustained L-arginine.

Synergistic Dual Delivery

By compounding 250 mg L-citrulline with 200 mg L-arginine, VapoCept establishes both rapid morning eNOS substrate availability and sustained plasma arginine retention, promoting hours of continuous microcapillary cerebral dilation.

About VapoCept's Formulation Approach

VapoCept integrates verified dosages of Niacin, L-Citrulline, L-Arginine, Beta-Alanine, Bacopa Monnieri, and Huperzia Serrata into a single 1-capsule daily serving backed by a 60-day refund window.

Claim Factory Stock · From $49 →